About Pia Rivera

Articles

Kairos Announces Closing of the Second and Final Tranche of its Fully Subscribed Private Placement

Energy Investing

Kairos Announces Closing of the Second and Final Tranche of its Fully Subscribed Private Placement

Kairos Capital Corporation (“Kairos” or the “Corporation”) (TSX-V:KRS) is pleased to announce that it has, subject to TSX Venture Exchange Inc. (the “TSXV”) final approval, closed the second and final tranche of its previously announced non-brokered private placement (the “Private Placement”) of common shares of the Corporation (“Common Shares”), pursuant

Equitorial Exploration’s 50/50 Joint Venture Magnesium Project with Mag One Products Inc. Will Not Require Environmental Evaluation

Critical Metals Investing

Equitorial Exploration’s 50/50 Joint Venture Magnesium Project with Mag One Products Inc. Will Not Require Environmental Evaluation

Equitorial Exploration Corp. (TSXV:EXX, Frankfurt: EE1, OTCQB: EQTXF) (“Equitorial” or “Company”) is pleased to report that the Company’s joint venture partner, Mag One Products Inc reported on October 12, 2017 that its commercial high-purity magnesium oxide (MgO) and silica (SiO2) project will not be subject to an environmental evaluation.

Triumph Gold Announces Multiple Diamond Drill Hole Intersections of Au-Cu Mineralization on Eastern Margin of The Revenue Diatreme Including 58.65 metres of 1.48 g/t Gold Equivalent* @ 0.971 grams/tonne Au and 0.22% Cu

Base Metals Investing

Triumph Gold Announces Multiple Diamond Drill Hole Intersections of Au-Cu Mineralization on Eastern Margin of The Revenue Diatreme Including 58.65 metres of 1.48 g/t Gold Equivalent* @ 0.971 grams/tonne Au and 0.22% Cu

Triumph Gold Corp., (TSX-V: TIG) (OTCMKTS: NFRGF) (“Triumph Gold” or the “Company”) is pleased to announce that diamond drilling along the relatively underexplored eastern margin of the Revenue diatreme has been rewarded with multiple intersections of copper, gold, silver +/- molybdenum mineralization.

PUF Ventures Enters Partnership with MYM Nutraceuticals to Build One Million Square Foot Cannabis Production Facility in Australia

Agriculture Investing

PUF Ventures Enters Partnership with MYM Nutraceuticals to Build One Million Square Foot Cannabis Production Facility in Australia

PUF Ventures Inc. (“PUF” or the “Company”) (CSE: PUF) (Frankfurt: PU3) (OTCPK: PUFXF), an advanced Access to Cannabis for Medical Purposes Regulations (“ACMPR”) license applicant, is pleased to announce that it has entered into a strategic partnership with MYM Nutraceuticals Inc. (CSE:MYM) (OTC:MYMMF) (“MYM”) for the construction of a one million square foot

Supreme Pharmaceuticals Announces Upsize of Previously Announced Bought Deal Private Placement to $35 Million

Agriculture Investing

Supreme Pharmaceuticals Announces Upsize of Previously Announced Bought Deal Private Placement to $35 Million

Supreme Pharmaceuticals Inc. (TSXV:FIRE) announced today that it has amended its agreement with Canaccord Genuity Corp., as lead underwriter on behalf of a syndicate of underwriters (the “Underwriters”), to increase the size of its previously announced bought deal private placement of convertible debenture units (the “Convertible Debenture Units”) to $35,000,000.

Cypress Closes Non-Brokered Private Placement Financing

Energy Investing

Cypress Closes Non-Brokered Private Placement Financing

Cypress Development Corp. (TSXV:CYP) (OTCBB: CYDVF) (Frankfurt: C1Z1) (“Cypress” or the “Company”) is pleased to announce that, further to its news releases of September 13, September 20, October 2 and October 5, the Company has closed its non-brokered private placement and issued 14,164,840 units (each, a “Unit”) at a subscription